(Q53241159)

English

Epitope spreading contributes to effective immunotherapy in metastatic melanoma patients.

scientific article published in June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21668310

Epitope spreading contributes to effective immunotherapy in metastatic melanoma patients. (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21668310

1 reference

based on heuristic

inferred from title

metastatic melanoma

1 reference

based on heuristic

inferred from title

Nicola Hardwick

1

object named as

Nicola Hardwick

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21668310

author name string

Benjamin Chain

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21668310

publication date

1 June 2011

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21668310

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21668310

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21668310

731-733

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21668310

6

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21668310

Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.62

21 January 2018

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.62

21 January 2018

Melanoma-associated antigen genes - an update

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.62

21 January 2018

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.62

21 January 2018

Driver clones and determinant spreading

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.62

21 January 2018

In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen.

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.62

21 January 2018

Determinant spreading and tumor responses after peptide-based cancer immunotherapy

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.62

21 January 2018

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.62

21 January 2018

Epitope spreading in immune-mediated diseases: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.62

21 January 2018

Immunotherapy for melanoma

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.62

21 January 2018

Identifiers

10.2217/IMT.11.62

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21668310

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21668310

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53241159&oldid=1681721821"